Taylor Wealth Management Partners’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,184
Closed -$346K 59
2022
Q1
$346K Sell
9,184
-1,020
-10% -$45.1K 0.14% 55
2021
Q4
$634K Sell
10,204
-10,164
-50% -$770K 0.22% 47
2021
Q3
$1.74M Sell
20,368
-465
-2% -$29.2K 0.62% 45
2021
Q2
$1.29M Buy
20,833
+686
+3% +$34.9K 0.45% 46
2021
Q1
$982K Sell
20,147
-8,408
-29% -$406K 0.36% 51
2020
Q4
$890K Sell
28,555
-1,565
-5% -$38.3K 0.34% 46
2020
Q3
$628K Sell
30,120
-295
-1% -$5.06K 0.29% 43
2020
Q2
$396K Sell
30,415
-5,810
-16% -$63.2K 0.2% 42
2020
Q1
$328K Sell
36,225
-4,595
-11% -$43.6K 0.2% 39
2019
Q4
$419K Sell
40,820
-62,030
-60% -$703K 0.19% 40
2019
Q3
$1.49M Sell
102,850
-190
-0.2% -$2.94K 0.7% 30
2019
Q2
$1.67M Buy
103,040
+1,760
+2% +$23.8K 0.78% 29
2019
Q1
$1.29M Buy
+101,280
New +$1.32M 0.64% 30

Other funds holding OPRX

Taylor Wealth Management Partners's OPRX Position: Q2 2022 in Review

Taylor Wealth Management Partners sold out of OptimizeRx (OPRX) in Q2 2022, closing a stake of 9,184 shares — an estimated $346K sold.

Taylor Wealth Management Partners first reported a position in OPRX in Q1 2019 and held it in 13 quarters. The position peaked at $1.74M in Q3 2021. 147 funds tracked by Wall St. Rank hold OPRX as of Q2 2022.

  • Taylor Wealth Management Partners reported no remaining OptimizeRx position as of Q2 2022 after selling out during the quarter.
  • Taylor Wealth Management Partners sold 9,184 OptimizeRx shares in Q2 2022, an estimated $346K.
  • Taylor Wealth Management Partners first reported a position in OptimizeRx in Q1 2019 and held it in 13 quarters.
  • Taylor Wealth Management Partners's OptimizeRx position peaked at $1.74M in Q3 2021.
  • 147 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2022.

Based on Taylor Wealth Management Partners's 13F filing for Q2 2022, filed 12 Aug 2022.